Skip to main content
Clinical Trials/NCT01165801
NCT01165801
Completed
Phase 4

Size Progression of Non-Exudative Age-Related Macular Degeneration After Cataract Surgery

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery1 site in 1 country54 target enrollmentJanuary 2002

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Age-Related Macular Degeneration
Sponsor
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Enrollment
54
Locations
1
Primary Endpoint
AMD size (defined central region of interest)
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study was to find out if in patients with non-exudative age-related macular degeneration (AMD), randomly assigned to cataract surgery, any AMD size progression or progression to exudative AMD could be detected 6 months after surgery.

Registry
clinicaltrials.gov
Start Date
January 2002
End Date
July 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Eligibility Criteria

Inclusion Criteria

  • Patients with cataract and non-exudative age-related macular degeneration

Exclusion Criteria

  • Patients with retinal pathologies other than AMD, exudative AMD, progressive glaucoma, myopia \> 10 diopters, panretinal laser treatment, former cataract or vitreoretinal surgery, were excluded.

Outcomes

Primary Outcomes

AMD size (defined central region of interest)

Time Frame: at enrollment, after 6 months

To evaluate AMD size progression, absolute and relative differences in pixels of the ROI were cal-culated by equivalent tests.

Secondary Outcomes

  • Functional ophthalmic assessments(at enrollment, after 6 months)

Study Sites (1)

Loading locations...

Similar Trials